These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1540232)

  • 1. Interaction of valproic acid and some analogues with microsomal epoxide hydrolase.
    Robbins DK; Wedlund PJ; Elsberg S; Oesch F; Thomas H
    Biochem Pharmacol; 1992 Feb; 43(4):775-83. PubMed ID: 1540232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valpromide inhibits human epoxide hydrolase.
    Pacifici GM; Franchi M; Bencini C; Rane A
    Br J Clin Pharmacol; 1986 Sep; 22(3):269-74. PubMed ID: 3094569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
    Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
    Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
    Spiegelstein O; Kroetz DL; Levy RH; Yagen B; Hurst SI; Levi M; Haj-Yehia A; Bialer M
    Pharm Res; 2000 Feb; 17(2):216-21. PubMed ID: 10751038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of metyrapone, chalcone epoxide, benzil, clotrimazole and related compounds on the activity of microsomal epoxide hydrolase in situ, in purified form and in reconstituted systems towards different substrates.
    Seidegård J; DePierre JW; Guenthner TM; Oesch F
    Eur J Biochem; 1986 Sep; 159(2):415-23. PubMed ID: 3758069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction.
    Eugster HP; Sengstag C; Hinnen A; Meyer UA; Würgler FE
    Biochem Pharmacol; 1991 Sep; 42(7):1367-72. PubMed ID: 1930259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate.
    Vogel-Bindel U; Bentley P; Oesch F
    Eur J Biochem; 1982 Aug; 126(2):425-31. PubMed ID: 7128597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
    Schladt L; Hartmann R; Timms C; Strolin-Benedetti M; Dostert P; Wörner W; Oesch F
    Biochem Pharmacol; 1987 Feb; 36(3):345-51. PubMed ID: 2880593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human liver cytosolic epoxide hydrolases.
    Schladt L; Thomas H; Hartmann R; Oesch F
    Eur J Biochem; 1988 Oct; 176(3):715-23. PubMed ID: 3169021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of the inhibition of styrene oxide and benzo(a)pyrene-4,5-oxide hydration in rat liver microsomes by cadmium.
    Parkki MG; Aitio A; Bend JR
    Biochim Biophys Acta; 1980 Aug; 614(2):625-8. PubMed ID: 7190847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the extra-mitochondrial CoA -ester formation of valproic and Delta4 -valproic acids.
    Aires CC; Ruiter JP; Luís PB; ten Brink HJ; Ijlst L; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochim Biophys Acta; 2007 Apr; 1771(4):533-43. PubMed ID: 17321204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoxide hydrolase in human fetal liver.
    Pacifici GM; Rane A
    Pharmacology; 1983; 26(5):241-8. PubMed ID: 6682981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase.
    Walters JM; Combes RD
    Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide.
    Kroetz DL; Loiseau P; Guyot M; Levy RH
    Clin Pharmacol Ther; 1993 Nov; 54(5):485-97. PubMed ID: 8222491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates.
    Müller F; Arand M; Frank H; Seidel A; Hinz W; Winkler L; Hänel K; Blée E; Beetham JK; Hammock BD; Oesch F
    Eur J Biochem; 1997 Apr; 245(2):490-6. PubMed ID: 9151984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific expression and differential inducibility of several microsomal epoxide hydrolase mRNAs which are formed by alternative splicing.
    Honscha W; Oesch F; Friedberg T
    Arch Biochem Biophys; 1991 Jun; 287(2):380-5. PubMed ID: 1840481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsubstituted amides: new class of potent inhibitors of human microsomal epoxide hydrolase.
    Kerr BM; Levy RH
    Drug Metab Dispos; 1990; 18(4):540-2. PubMed ID: 1976080
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective inhibition and selective induction of multiple microsomal epoxide hydrolases.
    Guenthner TM
    Biochem Pharmacol; 1986 Mar; 35(5):839-45. PubMed ID: 3954789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse liver microsomal cholesterol epoxide hydrolase: a specific inhibition of its activity by 5,6 alpha-Imino-5 alpha-cholestan-3 alpha-OL.
    Watabe T; Komatsu T; Isobe M; Tsubaki A
    Chem Biol Interact; 1983; 44(1-2):143-54. PubMed ID: 6406079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple epoxide hydrolases in human lung.
    Guenthner TM; Karnezis TA
    Drug Metab Dispos; 1986; 14(2):208-13. PubMed ID: 2870896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.